Cargando…
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
Animal models of multiple sclerosis (MS) have been extensively used to characterize the disease mechanisms in MS, as well as to identify potential pharmacologic targets for this condition. In recent years, the immune complement system has gained increased attention as an important effector in the pa...
Autores principales: | Saez-Calveras, Nil, Brewster, Amy L., Stuve, Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606595/ https://www.ncbi.nlm.nih.gov/pubmed/36311030 http://dx.doi.org/10.3389/fnmol.2022.1017484 |
Ejemplares similares
-
The role of the complement system in Multiple Sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022) -
Editorial: Animal models of multiple sclerosis: can they advance future therapies?
por: DeSilva, Tara Maria, et al.
Publicado: (2023) -
Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey, Divyanshu, et al.
Publicado: (2015) -
Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
por: Stopschinski, Barbara E., et al.
Publicado: (2023) -
Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)